nach oben

Erschienen in:

02.06.2022

The impact of toxic oil syndrome on physical and psychological health status using the HAQ and the PHQ-9 questionnaires

verfasst von: Macarena Garrido-Estepa, Greta Arias-Merino, Verónica Alonso-Ferreira, Ana Villaverde-Hueso, Manuel Posada de la Paz

Erschienen in: Quality of Life Research | Ausgabe 10/2022

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Background

Toxic oil syndrome (TOS) is a multisystemic disease due to a massive intoxication. To evaluate physical and mental health of TOS patients, we used the Health Assessment Questionnaire (HAQ) and the Patient Health Questionnaire–9 (PHQ-9). Additionally, we correlated both questionnaires with the results of the Short Form-36v2 (SF-36v2) Health Survey obtained in the same patients’ sample.

Methods

895 TOS patients who participated in the prior SF-36v2 study were invited to participate. We described patients’ demographic and clinical characteristics, HAQ and PHQ-9 results. HAQ and PHQ-9 scores were correlated to the standardised SF-36v2 results obtained in our previous study.

Results

In total, 828 (92.5%) TOS annual follow-up and HAQ and 810 (90.5%) PHQ-9 valid questionnaires were analysed. Participants’ average age was 65.4 (Standard Deviation (SD): 13.4), 521 (62.9%) were women, 725 (87.6%) reported having at least other chronic disease and 789 (95.3%) an additional TOS-related health problem. Average scores were 0.91 (SD: 0.83) for HAQ, 35.8 (SD: 10.1) for PCS and 37.8 (SD: 11.6) for MCS. Overall, 467 (57.7%) participants had moderate/severe depression (PHQ-9 ≥ 10), but only 229 (49.6%) of them reported having a depression diagnosis. Correlation between questionnaires was very strong for HAQ and physical function SF-36v2 dimension and moderate/fair for the rest of combinations.

Conclusions

TOS cohort presented low/very low health status measured with SF-36v2, moderate difficulties in performing daily activities according to HAQ, and a high prevalence of major depression measured with PHQ-9. High proportion of undiagnosed depression was detected, proving PHQ-9 useful in terms of detecting and promoting depression diagnosis in the cohort.

Vorheriger Artikel Multidimensional frailty and quality of life: data from the English Longitudinal Study of Ageing

Nächster Artikel Longitudinal associations between perception of future time and subjective well-being among middle-aged and older people in China: the moderating roles of individual health and socioeconomic status

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Nur mit Berechtigung zugänglich

Manuel Tabuenca, J. (1981). Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. The Lancet, 318, 567–568. https://doi.org/10.1016/S0140-6736(81)90949-1CrossRef

Posada de la Paz, M., Philen, R. M., Schurz, H., Hill, R. H., Giménez Ribota, O., Gómez de la Camara, A., et al. (1999). Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome. Epidemiology (Cambridge), 10, 130–134.CrossRef

de la Paz, M. P., Philen, R. M., & Borda, I. A. (2001). Toxic oil syndrome: The perspective after 20 years. Epidemiologic Reviews, 23, 231–247. https://doi.org/10.1093/oxfordjournals.epirev.a000804CrossRef

Valadés, P. S.-P., Paz, M. P. de la, Copa, P. de A., Ribota, O. G., & Borda, I. (2003). Toxic oil syndrome: Survival in the whole cohort between 1981 and 1995. Journal of Clinical Epidemiology, 56, 701–708. https://doi.org/10.1016/S0895-4356(03)00119-7.CrossRef

Alonso-Ruiz, A., Zea-Mendoza, A. C., Salazar-Vallinas, JoséM., Rocamora-Ripoll, A., & Beltrán-Gutiérrez, J. (1986). Toxic oil syndrome: A syndrome with features overlapping those of various forms of scleroderma. Seminars in Arthritis and Rheumatism, 15, 200–212. https://doi.org/10.1016/0049-0172(86)90017-x.CrossRefPubMed

Abaitua Borda, I., Philen, RM., Posada de la Paz, M., Gómez de la Cámara, A., Díez Ruiz-Navarro, M., Giménez Ribota, O., Alvargonzález Soldevilla, J., Terracini, B., Severiano Peña, S., Fuentes Leal, C., & Kilbourne, EM. (1998). Toxic oil syndrome mortality: The first 13 years. International Journal of Epidemiology, 27, 1057–1063. https://doi.org/10.1093/ije/27.6.1057.CrossRefPubMed

Abaitua Borda, I., Kilbourne, EM., Posada de la Paz, M., Diez Ruiz-Navarro, M., Gabriel Sanchez, R., & Falk, H. (1993). Mortality among people affected by toxic oil syndrome. International Journal of Epidemiology, 22, 1077–1084. https://doi.org/10.1093/ije/22.6.1077.CrossRefPubMed

The Whoqol Group. (1998). The world health organization quality of life assessment (WHOQOL): Development and general psychometric properties. Social Science and Medicine, 46, 1569–1585. https://doi.org/10.1016/S0277-9536(98)00009-4CrossRef

OECD. (2017). “Perceived health status”, in Health at a Glance 2017: OECD Indicators. OECD. https://doi.org/10.1787/health_glance-2017-enCrossRef

10.

Gómez de la Cámara, A., Posada de la Paz, M., Abaitua Borda, I., Barainca Oyagüe, M. T., Abraira Santos, V., Ruiz-Navarro, M. D., & Terracini, B. (1998). Health status measurement in toxic oil syndrome. Journal of Clinical Epidemiology, 51, 867–873. https://doi.org/10.1016/S0895-4356(98)00062-6.CrossRefPubMed

11.

Posada de la Paz, M., Díaz-Guerra, E., Alonso-Ferreira, V., Villaverde-Hueso, A., Arias-Merino, G., & Garrido-Estepa, M. (2021). Toxic oil syndrome: health-related quality-of-life assessment using the SF-36 health survey. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyab127.CrossRef

12.

Alonso, J., Anto, J. M., & Moreno, C. (1990). Spanish version of the nottingham health profile: Translation and preliminary validity. American Journal of Public Health, 80, 704–708. https://doi.org/10.2105/AJPH.80.6.704CrossRefPubMedPubMedCentral

13.

Bruce, B., & Fries, J. F. (2003). The stanford health assessment questionnaire: Dimensions and practical applications. Health and Quality of Life Outcomes, 1, 20. https://doi.org/10.1186/1477-7525-1-20CrossRefPubMedPubMedCentral

14.

National Institute of Clinical Excellent (NICE) (2009). Depression in adults with a chronic physical health problem: recognition and management. NICE Clinical Guidance [GP91]. Retrieved June 1, 2022, from https://www.nice.org.uk/Guidance/CG91.

15.

Manea, L., Gilbody, S., & McMillan, D. (2012). Optimal cut-off score for diagnosing depression with the patient health questionnaire (PHQ-9): A meta-analysis. Canadian Medical Association Journal, 184, E191–E196. https://doi.org/10.1503/cmaj.110829CrossRefPubMedPubMedCentral

16.

Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.xCrossRefPubMedPubMedCentral

17.

Esteve-Vives, J., Batlle-Gualda, E., & Reig, A. (1993). Spanish version of the health assessment questionnaire: Reliability, validity and transcultural equivalency. Grupo para la Adaptación del HAQ a la Población Española. Journal of Rheumatology, 20, 2116–2122.PubMed

18.

Diez-Quevedo, C., Rangil, T., Sanchez-Planell, L., Kroenke, K., & Spitzer, R. L. (2001). Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital spanish inpatients. Psychosomatic Medicine, 63, 679–686. https://doi.org/10.1097/00006842-200107000-00021.CrossRefPubMed

19.

Bruce, B., & Fries, J. F. (2003). The stanford health assessment questionnaire: A review of its history, issues, progress, and documentation. Journal of Rheumatology, 30, 167–178.PubMed

20.

21.

Ware, J.E., Kosinski, M., Bjorner, J.B., Turner - Bowker, D.M., Gandek, B., & Maruish, M.E. (2007). User's manual for the SF - 36v2 Health Survey (2nd ed.). Lincoln, RI: Quality Metric Incorporated.

22.

Ware JE, Kosinski M, Dewey JE (2000) How to Score Version 2 of the SF-36 (R) Health Survey. Lincon, RI: QualityMetric Incorporated.

23.

Ware JE, Kosinski M, Keller SD (1994) SF-36 Physical and Mental Health Summary Scales: A User’s Manual Boston, MA: The Health Institute.

24.

Alonso, J., Regidor, E., Barrio, G., Prieto, L., Rodríguez, C., & de la Fuente, L. (1998). Population reference values of the Spanish version of the health questionnaire SF-36. Medicina Clínica (Barcelona), 111, 410–416.

25.

Silveira, E., Taft, C., Sundh, V., Waern, M., Palsson, S., & Steen, B. (2005). Performance of the SF-36 Health Survey in screening for depressive and anxiety disorders in an elderly female Swedish population. Quality of Life Research, 14, 1263–1274. https://doi.org/10.1007/s11136-004-7753-5.CrossRefPubMed

26.

Chan, Y. H. (2003). Biostatistics 104: Correlational analysis. Singapore Medical Journal, 44, 614–619.PubMed

27.

Akoglu, H. (2018). User’s guide to correlation coefficients. Turkish Journal of Emergency Medicine, 18, 91–93. https://doi.org/10.1016/j.tjem.2018.08.001CrossRefPubMedPubMedCentral

28.

Gelpí, E., de la Paz, M. P., Terracini, B., Abaitua, I., de la Cámara, A. G., Kilbourne, E. M., Lahoz, C., Nemery, B., Philen, R. M., Soldevilla, L., Tarkowski, S., & WHO/CISAT Scientific Committee for the Toxic Oil Syndrome. Centro de Investigación para el Síndrome del Aceite Tóxico. The Spanish Toxic Oil Syndrome 20 Years after Its Onset: A Multidisciplinary Review of Scientific Knowledge. (2002). The Spanish toxic oil syndrome 20 years after its onset: A multidisciplinary review of scientific knowledge. Environmental Health Perspectives, 110, 457–464. https://doi.org/10.1289/ehp.110-1240833CrossRefPubMedPubMedCentral

29.

Löwe, B., Unützer, J., Callahan, C. M., Perkins, A. J., & Kroenke, K. (2004). Monitoring depression treatment outcomes with the patient health questionnaire-9. Medical Care, 42, 1194–1201. https://doi.org/10.1097/00005650-200412000-00006CrossRefPubMed

30.

Sánchez-García, J. C., Cortés-Martín, J., Rodríguez-Blanque, R., Marín-Jiménez, A. E., Montiel-Troya, M., & Díaz-Rodríguez, L. (2021). Depression and anxiety in patients with rare diseases during the COVID-19 pandemic. International Journal of Environmental Research and Public Health, 18, 3234. https://doi.org/10.3390/ijerph18063234CrossRefPubMedPubMedCentral

31.

Uhlenbusch, N., Löwe, B., Härter, M., Schramm, C., Weiler-Normann, C., & Depping, M. K. (2019). Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study. PLOS ONE, 14, e0211343. https://doi.org/10.1371/journal.pone.0211343CrossRefPubMedPubMedCentral

32.

Lohr, J. B., Palmer, B. W., Eidt, C. A., Aailaboyina, S., Mausbach, B. T., Wolkowitz, O. M., Thorp, S. R., & Jeste, D. V. (2015). Is Post-traumatic stress disorder associated with premature senescence? A Review of the literature. The American Journal of Geriatric Psychiatry, 23, 709–725. https://doi.org/10.1016/j.jagp.2015.04.001CrossRefPubMedPubMedCentral

33.

Lopez-Ibor, J. J., & Jimenez Arriero, M. A. (1987). Psychosocial rehabilitation in disasters: Experience of the Spanish toxic oil syndrome. International Disability Studies, 9, 81–83. https://doi.org/10.3109/03790798709166243CrossRefPubMed

34.

Birrell, F. N., Hassell, A. B., Jones, P. W., & Dawes, P. T. (2000). How does the Short Form 36 Health Questionnaire (SF-36) in Rheumatoid Arthritis (RA) Relate to RA Outcome Measures and SF-36 Population Values? A Cross-Sectional Study. Clinical Rheumatology, 19, 195–199. https://doi.org/10.1007/s100670050155CrossRefPubMed

35.

Iudici, M., Cuomo, G., Vettori, S., Avellino, M., & Valentini, G. (2013). Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease. Health and Quality of Life Outcomes, 11, 23. https://doi.org/10.1186/1477-7525-11-23CrossRefPubMedPubMedCentral

36.

Danieli, E., Airò, P., Bettoni, L., Cinquini, M., Antonioli, C. M., Cavazzana, I., Franceschini, F., & Cattaneo, R. (2005). Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clinical Rheumatology, 24, 48–54. https://doi.org/10.1007/s10067-004-0970-zCrossRefPubMed

37.

Alonso-Ruiz, A., Calabozo, M., Perez-Ruiz, F., & Mancebo, L. (1993). Toxic Oil Syndrome A Long-term Follow-up of a Cohort of 332 Patients: Medicine (Baltimore), 72, 285–295. https://doi.org/10.1097/00005792-199309000-00001CrossRef

38.

Martín Alvarez, H., Plaza Cano, M., Estirado de Cabo, E., García de Aguinaga, M., Izquierdo Martínez, M., & Posada de la Paz, M. (2000). Hallazgos clínicos y analíticos en pacientes afectados por el síndrome del aceite tóxico. Estudio de una cohorte de 758 pacientes. Revista Clínica Española, 200, 305–309. https://doi.org/10.1016/S0014-2565(00)70642-4CrossRefPubMed

39.

Gómez de la Cámara, A., Gómez Mateos, M. A., Ferrando Vivas, P., Barianca Oyagüe, M. T., Abiatua Borda, I., & Posada de la Paz, M. (2003). Prevalencia de factores de riesgo cardiovascular en una cohorte de afectados por el síndrome del aceite tóxico. Medicina Clínica, 121, 405–407. https://doi.org/10.1016/S0025-7753(03)73969-4CrossRefPubMed

Titel: The impact of toxic oil syndrome on physical and psychological health status using the HAQ and the PHQ-9 questionnaires
verfasst von: Macarena Garrido-Estepa
Greta Arias-Merino
Verónica Alonso-Ferreira
Ana Villaverde-Hueso
Manuel Posada de la Paz
Publikationsdatum: 02.06.2022
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 10/2022
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-022-03161-8

Springer Professional

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Wirtschaft"

Weitere Artikel der Ausgabe 10/2022

The prototype of a preference-based index of weight-related quality of life: demonstrating the possibilities

A qualitative investigation of the relevance of skin irritation and self-confidence bolt-ons and their conceptual overlap with the EQ-5D in patients with psoriasis

Reducing waste in collection of quality-of-life data through better reporting: a case study

Reducing research wastage by starting off on the right foot: optimally framing the research question

Pain interference and health-related quality of life in caregivers of service members and veterans with traumatic brain injury and mental health comorbidity

Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews

Premium Partner